Reinduction of Bevacizumab in Combination with Pegylated Liposomal Doxorubicin in a Patient with Recurrent Glioblastoma Multiforme Who Progressed on Bevacizumab/Irinotecan

Glioblastoma multiforme (GBM) carries a dismal prognosis despite the current standard of multimodality treatments. Recent studies showed promising results to a regimen consisting of a VEGF inhibitor, (bevacizumab) and a topoisomerase I inhibitor (irinotecan) [BI] in recurrent GBM. However, those pat...

Full description

Saved in:
Bibliographic Details
Main Authors: Almubarak, Mohammed, Newton, Michael, Altaha, Ramin
Format: Artigo
Language:Inglês
Published: Hindawi Publishing Corporation 2008
Subjects:
Case Report
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2648641/
https://ncbi.nlm.nih.gov/pubmed/19259336
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2008/942618
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items